Mon, 27 September 2021
In this special episode on SGLT-2 inhibitors and CKD Drs. John Russell and Neil Skolnik discuss the effects of the SGLT-2 inhibitors in decreasing progression of chronic kidney disease. This special episide is supported by independent educational grant from AstraZeneca.
For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.
Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health
John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health
Direct download: Diabetes_Core_Update_SGLT2s_and_Diabetic_Kidney_Disease.mp3
Category:Medical -- posted at: 3:00am PDT